Healthcare

agilon health (NYSE: AGL) climbed 13.14% to $93.57 on June 4, extending a powerful rally as investors continued to price in a sharper earnings recovery. The stock moved close to its 52-week high of $94.71, signalling renewed market confidence in the company’s value-based care …

Alignment Healthcare Gains on Growth Recognition

A Sale That Fixes Two Problems at Once

Verastem Oncology (NASDAQ: VSTM) moved higher after the US Food and Drug Administration granted Fast Track Designation to VS-7375, the company’s oral investigational selective KRAS G12D inhibitor, for a defined group of patients with advanced or metastatic non-small cell lung cancer.

Splash Beverage Group (NYSE American: SBEV) surged 65.87% in pre-market trading on June 4th, 2026, advancing from $0.24 to $0.40 per share, following June 3rd announcement of NYSE American compliance plan submission addressing stockholders' equity deficiency notice received April 29th.

Co-Diagnostics, Inc. (NASDAQ: CODX) fell roughly 16.88% to about $5.17 on 3 June 2026, ranking among the day's notable decliners. The molecular-diagnostics company saw its shares drop sharply in a session marked by unusually light trading volume, even as the company had recently reported …

Cingulate (Nasdaq:CING) is a clinical-stage biopharmaceutical company focused on developing treatments for attention-Deficit/hyperactivity disorder, or ADHD. Its core strategy is built around a proprietary drug-delivery platform designed to release medication in timed doses over the course of a day.